Dr. Reddy's Laboratories launches Versavo in the UK
Versavo is the first Dr. Reddy's biosimilar product to be approved and launched in the UK
Versavo is the first Dr. Reddy's biosimilar product to be approved and launched in the UK
Winlevi is indicated for the topical treatment of acne vulgaris in patients 12 years of age and older
Grand opening of the joint venture between Evonik China and Shandong Vland Biotech in Qingdao, China
More than 10,000 scientific publications containing EUDRAGIT
Strategic multi-year research collaboration to identify novel targets with strong disease links and to accelerate clinical development
Sen spent a decade with Biocon and held various key roles,
Dalal is an experienced leader at Abbott, having joined in 1995 as a Product Manager
Company reaffirms commitment to reduce the global burden of HPV-related diseases, including certain cancers
Completes acquisition of 75% of share capital from Glenmark Pharmaceuticals
Subscribe To Our Newsletter & Stay Updated